Loading...
19P logo

Phreesia, Inc.DB:19P Stock Report

Market Cap €484.6m
Share Price
€7.85
€14.34
45.3% undervalued intrinsic discount
1Y-62.5%
7D2.6%
Portfolio Value
View

Phreesia, Inc.

DB:19P Stock Report

Market Cap: €484.6m

19P Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Phreesia, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Phreesia
Historical stock prices
Current Share PriceUS$7.85
52 Week HighUS$27.48
52 Week LowUS$6.85
Beta0.86
1 Month Change-22.51%
3 Month Change-40.84%
1 Year Change-62.55%
3 Year Change-72.55%
5 Year Change-82.08%
Change since IPO-62.89%

Recent News & Updates

Recent updates

Shareholder Returns

19PDE Healthcare ServicesDE Market
7D2.6%-1.1%-0.3%
1Y-62.5%15.8%4.9%

Return vs Industry: 19P underperformed the German Healthcare Services industry which returned 17.3% over the past year.

Return vs Market: 19P underperformed the German Market which returned 6% over the past year.

Price Volatility

Is 19P's price volatile compared to industry and market?
19P volatility
19P Average Weekly Movement10.0%
Healthcare Services Industry Average Movement5.0%
Market Average Movement5.9%
10% most volatile stocks in DE Market13.9%
10% least volatile stocks in DE Market2.6%

Stable Share Price: 19P's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 19P's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
20051,789Chaim Indigwww.phreesia.com

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks.

Phreesia, Inc. Fundamentals Summary

How do Phreesia's earnings and revenue compare to its market cap?
19P fundamental statistics
Market cap€484.59m
Earnings (TTM)€1.97m
Revenue (TTM)€411.24m
233.2x
P/E Ratio
1.1x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
19P income statement (TTM)
RevenueUS$480.59m
Cost of RevenueUS$154.12m
Gross ProfitUS$326.47m
Other ExpensesUS$324.16m
EarningsUS$2.31m

Last Reported Earnings

Jan 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)0.038
Gross Margin67.93%
Net Profit Margin0.48%
Debt/Equity Ratio27.5%

How did 19P perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/23 17:06
End of Day Share Price 2026/04/23 00:00
Earnings2026/01/31
Annual Earnings2026/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Phreesia, Inc. is covered by 23 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joseph VruwinkBaird
Glen SantangeloBarclays
Zhilin LongBerenberg